Increased acylcarnitines in infant heart failure indicate fatty acid oxidation inhibition: towards therapeutic options?

Issa, Jean; Lodewyckx, Pierre; Blasco, Hélène; Benz-de-Bretagne, Isabelle; Labarthe, François; Lefort, Bruno

Issa, Jean; Lodewyckx, Pierre; Blasco, Hélène; Benz-de-Bretagne, Isabelle; Labarthe, François; Lefort, Bruno.

Afiliação

Issa J; Institut des Cardiopathies Congénitales de Tours, Hôpital Gatien de Clocheville, CHU Tours, 49 Boulevard Béranger, Tours, 37000, France.
Lodewyckx P; Université François Rabelais, Tours, France.
Blasco H; Institut des Cardiopathies Congénitales de Tours, Hôpital Gatien de Clocheville, CHU Tours, 49 Boulevard Béranger, Tours, 37000, France.
Benz-de-Bretagne I; Université François Rabelais, Tours, France.
Labarthe F; Université François Rabelais, Tours, France.
Lefort B; Service de Biochimie et Biologie Moléculaire, CHU Tours, Tours, France.

ESC Heart Fail ; 10(5): 3114-3122, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37614055

Palavras-chave

Acylcarnitines; Children; Dilated cardiomyopathy; Fatty acid beta-oxidation; Heart failure

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: ESC Heart Fail Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França